Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 2,041 results from 1 sources
https://web.expasy.org/cellosaurus/CVCL_2813

Cite this: (JCRB Cat# JCRB0518, RRID:CVCL_2813)
Organism: Homo sapiens
Disease:
Category: Finite cell line
Comment:

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_AR97

Cite this: (JCRB Cat# NIHS0315, RRID:CVCL_AR97)
Organism: Homo sapiens
Disease:
Category: Finite cell line
Comment: Discontinued: JCRB; NIHS0315.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_JG87

Cite this: (JCRB Cat# JCRB1695, RRID:CVCL_JG87)
Organism: Homo sapiens
Disease:
Category: Transformed cell line
Comment:

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_JH16

Cite this: (JCRB Cat# JCRB3034, RRID:CVCL_JH16)
Organism: Homo sapiens
Disease:
Category: Finite cell line
Comment:

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_LC41

Cite this: (JCRB Cat# JCRB1721, RRID:CVCL_LC41)
Organism: Macaca fascicularis
Disease:
Category: Finite cell line
Comment: Group: Non-human primate cell line.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0001

Cite this: (JCRB Cat# JCRB0062, RRID:CVCL_0001)
Organism: Homo sapiens
Disease: Erythroleukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: ~24 hours (PubMed=6177045); ~36 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for JAK2 p.Val617Phe (PubMed=16408098). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (JCRB Cat# JCRB0085, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (JCRB Cat# JCRB0019, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (JCRB Cat# JCRB0112, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (JCRB Cat# JCRB0112.1, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0007

Cite this: (JCRB Cat# JCRB9021, RRID:CVCL_0007)
Organism: Homo sapiens
Disease: Adult acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Characteristics: Can be induced to differentiate into macrophages by several factors such as phorbol ester (PMA) and 12-O-tetradecanoyl-13-phorbol acetate (TPA). Doubling time: 95-100 hours (PubMed=178611); ~30-40 hours (DSMZ). Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Proteome analysis by 2D-DE/MS. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: ATCC; CRL-1593. Discontinued: RCB; RCB1978.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (JCRB Cat# JCRB9071, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0013

Cite this: (JCRB Cat# JCRB9031, RRID:CVCL_0013)
Organism: Homo sapiens
Disease: Adult T acute lymphoblastic leukemia
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel. Part of: NCI60 cancer cell line panel. Doubling time: 31.56 +- 1.488 hours (PubMed=24762992); 33 hours (PubMed=17117183); 29 hours (PubMed=20922763); 27.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Instable (MSI-high) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Cys (PubMed=17088437). Sequence variation: Homozygous for PTEN p.Lys267fs*9 (PubMed=17088437). Sequence variation: Heterozygous for STK11 p.Gln214Ter (PubMed=17088437). Sequence variation: Heterozygous for TP53 p.Arg306Ter (PubMed=17088437). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0014

Cite this: (JCRB Cat# JCRB0034, RRID:CVCL_0014)
Organism: Homo sapiens
Disease: Plasma cell myeloma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Characteristics: Produces IgG lambda. Doubling time: 60 hours (PubMed=25984343); 33.5 hours (NCI-DTP); ~60-70 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for EGFR p.Thr751Ile (PubMed=17088437). Sequence variation: Heterozygous for KRAS p.Gly12Ala (PubMed=11157491; PubMed=17088437). Sequence variation: Homozygous for TP53 p.Glu285Lys; temperature-sensitive (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: RPMI-8266; Occasionally. Misspelling: RPMI-8826; In Cosmic 875867. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0023

Cite this: (JCRB Cat# JCRB0076, RRID:CVCL_0023)
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: A594; In PubMed=18227028. Misspelling: A59; In PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0027

Cite this: (JCRB Cat# JCRB1054, RRID:CVCL_0027)
Organism: Homo sapiens
Disease: Hepatoblastoma
Category: Cancer cell line
Comment: Problematic cell line: Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877). Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: JFCR45 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Doubling time: ~50-60 hours (DSMZ). Sequence variation: NRAS p.Gln61Leu (PubMed=8389256). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Secretome proteome analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Discontinued: JCRB; NIHS0326. Discontinued: RCB; RCB0459.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0027

Cite this: (JCRB Cat# NIHS0326, RRID:CVCL_0027)
Organism: Homo sapiens
Disease: Hepatoblastoma
Category: Cancer cell line
Comment: Problematic cell line: Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877). Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: JFCR45 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Doubling time: ~50-60 hours (DSMZ). Sequence variation: NRAS p.Gln61Leu (PubMed=8389256). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Secretome proteome analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Discontinued: JCRB; NIHS0326. Discontinued: RCB; RCB0459.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0030

Cite this: (JCRB Cat# JCRB9004, RRID:CVCL_0030)
Organism: Homo sapiens
Disease: Human papillomavirus-related endocervical adenocarcinoma
Category: Cancer cell line
Comment: Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Characteristics: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(qll;q11q13;q24) and der(22)t(8;22)(q24;q13). Doubling time: ~48 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep membrane proteome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep quantitative proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: Glycoproteome analysis by proteomics. Omics: Myristoylated proteins analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line. Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377). Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line. Miscellaneous: HeLa is the most frequent contributor to cell lines contamination. Discontinued: ATCC; CRL-7923.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0031

Cite this: (JCRB Cat# JCRB0134, RRID:CVCL_0031)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.Glu545Lys (PubMed=17088437). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Misspelling: MFC-7; Occasionally. Discontinued: ATCC; CRL-12584. Discontinued: JCRB; NIHS0200. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0031

Cite this: (JCRB Cat# NIHS0200, RRID:CVCL_0031)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.Glu545Lys (PubMed=17088437). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Misspelling: MFC-7; Occasionally. Discontinued: ATCC; CRL-12584. Discontinued: JCRB; NIHS0200. Derived from metastatic site: Pleural effusion.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X